Immunization, Hib3 in Canada
Canada: Immunization, Hib3 was 90.0% in 2024. ▬ Flat
Immunization, Hib3 in Canada, 1996–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Canada is 90.0%, measured in 2024.
That represents a change of down 1.1% over ten years.
Over the whole period, immunization, hib3 in Canada peaked at 95.0% in 2006 and was at its lowest, 84.0%, in 1996.
Canada ranks 101st of 191 countries on this measure, in the middle of the range.
Immunization, Hib3 in Canada, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1996 | 84.0% | — |
| 1997 | 87.0% | +3.6% |
| 1998 | 88.0% | +1.1% |
| 1999 | 88.0% | +0.0% |
| 2000 | 88.0% | +0.0% |
| 2001 | 88.0% | +0.0% |
| 2002 | 88.0% | +0.0% |
| 2003 | 88.0% | +0.0% |
| 2004 | 91.0% | +3.4% |
| 2005 | 93.0% | +2.2% |
| 2006 | 95.0% | +2.2% |
| 2007 | 93.0% | -2.1% |
| 2008 | 92.0% | -1.1% |
| 2009 | 91.0% | -1.1% |
| 2010 | 90.0% | -1.1% |
| 2011 | 89.0% | -1.1% |
| 2012 | 90.0% | +1.1% |
| 2013 | 91.0% | +1.1% |
| 2014 | 91.0% | +0.0% |
| 2015 | 91.0% | +0.0% |
| 2016 | 91.0% | +0.0% |
| 2017 | 91.0% | +0.0% |
| 2018 | 91.0% | +0.0% |
| 2019 | 92.0% | +1.1% |
| 2020 | 92.0% | +0.0% |
| 2021 | 92.0% | +0.0% |
| 2022 | 90.0% | -2.2% |
| 2023 | 90.0% | +0.0% |
| 2024 | 90.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 86.8% | 84.0% | 88.0% | 4 |
| 2000s | 90.7% | 88.0% | 95.0% | 10 |
| 2010s | 90.7% | 89.0% | 92.0% | 10 |
| 2020s | 90.8% | 90.0% | 92.0% | 5 |
Countries ranked near Canada
More health data for Canada
- Un projection of annual infant deaths, annual growth rate -1.79 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3588 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,083 deaths per 1,000 people (2090)
- Number of infants who die before age 1 385 deaths (2100)
- Population ages 30-34, female, annual growth rate 0.2226 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0349 units per person (2025)
- Population ages 30-34, male, annual growth rate 0.8642 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0369 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Canada?
- Immunization, hib3 in Canada was 90.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Canada?
- The highest recorded value was 95.0% in 2006.
- What is the lowest immunization, hib3 recorded in Canada?
- The lowest recorded value was 84.0% in 1996.
- How does Canada rank for immunization, hib3?
- Canada ranks 101st out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Canada?
- Over the last ten years it is down 1.1%. The long-run trend across the full record is flat.
- Where does this Canada data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.